[Federal Register: October 31, 2006 (Volume 71, Number 210)]
[Page 63773-63774]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Vaccines and Related Biological Products Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Vaccines and Related Biological Products 
Advisory Committee
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held via teleconference on 
November 16, 2006 from 1 p.m. to 5 p.m.
    Location: NIH campus, Food and Drug Administration Bldg. 29B, 
Conference Room C, 8800 Rockville Pike, Bethesda, MD. This meeting will 
be held by teleconference. The public is welcome to attend the meeting 
at the above location. A speakerphone will be provided at the specified 
location for public participation in this meeting. Important 
information about transportation and directions to the NIH campus, 
parking, and security procedures is available on the internet at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.nih.gov/about/visitor/index.htm.
 Visitors must show two forms of 

identification such as a Federal employee badge, driver's license, 
passport, green card, etc. If you are planning to drive to and park on 
the NIH campus, you must enter at the South Drive entrance of the 
campus which is located on Wisconsin Ave. (the medical center metro 
entrance), and allow extra time for vehicle inspection. Detailed 
information about security procedures is located at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.nih.gov/about/visitorsecurity.htm.
 Due to the limited available parking, 

visitors are encouraged to use public transportation.
    Contact Person: Christine Walsh or Denise Royster, Center for 
Biologics Evaluation and Research (HFM-71), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 3014512391. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: The committee will hear an overview on the operations of 
the Laboratory of Bacterial Toxins, Division of Bacterial, Parasitic, 
and Allergenic Products; and the Laboratory of Vector Borne Virus 
Diseases, the Laboratory of Hepatitis Viruses, and the Laboratory of

[[Page 63774]]

Respiratory Viral Diseases, Division of Viral Products, Office of 
Vaccines Research and Review, CBER, and in closed session will discuss 
the reports from the laboratory site visits of December 6, 2005, 
January 11, 2006, and June 29, 2006.
    Procedure: On November 16, 2006, from 1 p.m. to 3:55 p.m., the 
meeting is open to the public. Interested persons may present data, 
information, or views, orally or in writing, on issues pending before 
the committee. Written submissions may be made to the contact person by 
November 9, 2006. Oral presentations from the public will be scheduled 
between approximately 2:55 p.m. to 3:55 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before November 9, 2006 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Closed Committee Deliberations: On November 16, 2006 from 3:55 p.m. 
to 5 p.m. the meeting will be closed to permit discussion where 
disclosure would constitute a clearly unwarranted invasion of personal 
privacy (5 U.S.C. 552b(c)(6)). The committee will discuss a review of 
internal research programs in the Office of Vaccines Research and 
Review, Division of Viral Products and Division of Bacterial Parasitic 
and Allergenic Products, Center for Biologics Evaluation and Research.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Christine Walsh or 
Denise Royster at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: October 26, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E6-18314 Filed 10-30-06; 8:45 am]